An updated systematic review and meta-analysis exploring the efficacy and safety of dimethyl fumarate (DMF) for patients with multiple sclerosis (MS)
DMF had significant efficacy and safety compared with the control, with no difference between the DMF doses. More studies with large sample sizes and longer follow-ups are needed to detect long-term safety and efficacy.
Authors
- Amr Mahmoud Yousef (ORCID: https://orcid.org/0000-0001-7529-0645)
- Hossam Tharwat Ali (ORCID: https://orcid.org/0000-0001-8077-5911)
- Hazem Khaled Hassaan (ORCID: https://orcid.org/0009-0003-9868-3232)
- Ahmed M. Afifi
- Amr El‐Sayed (ORCID: https://orcid.org/0009-0004-1803-9090)
- A. Mahmoud (ORCID: https://orcid.org/0000-0002-8943-3368)
- Sara Hosny El-Farargy (ORCID: https://orcid.org/0000-0002-3691-7772)
- Ahmed Mohamed Abdelmonhem
- Dalia Atef Abouda (ORCID: https://orcid.org/0009-0000-5265-2447)
Institutions
- Ain Shams University (EG)
- University of Toledo Medical Center (US)
- South Valley University (EG)
- Benha University (EG)
- Alexandria University (EG)
Publication Details
- Journal
- BMJ Neurology Open
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/bmjno-2024-000872
- Citations
- 3
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.27